← FDA Drug Approvals (Drugs@FDA)
TERIPARATIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2023-11-16
Drug application
- FDA Application #
ANDA211097- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TERIPARATIDE
- Generic name
- Teriparatide
- Active ingredients
- TERIPARATIDE
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- APOTEX
- First approval
- 2023-11-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown